PRESENTATION

Q3 2021 — Earnings presentation

Q3 2021PDF · 16 pages385 KB
2021
Third Quarter
Earnings
(Unaudited)
October 26, 2021

-- 1 of 16 --

22	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Events
2021 Earnings Calls
Q4 January 25

-- 2 of 16 --

33	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Forward looking statement
This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and
uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will,"
"should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance
or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory,
capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the
operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus
(COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning
various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5)
legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form
10-K for the year ended Dec. 31, 2020, and any subsequent quarterly reports on Form 10-Q (the “Reports”); (6) competitive conditions and customer preferences;
(7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials, labor, and energy
(including oil and natural gas and their derivatives) due to shortages, increased demand and wages, logistics, manufacturing site disruption or supply chain
interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a
global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the
impact of acquisitions, strategic alliances, divestitures and other unusual events resulting from portfolio management actions and other evolving business
strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity
improvements than estimated; (12) financial market risks that may affect the Company’s funding obligations under defined benefit pension and postretirement
plans; (13) the Company's credit ratings and its cost of capital; and (14) tax-related external conditions, including changes in tax rates, laws or regulations. Changes
in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note
Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly
Reports), as updated by applicable Current Reports on Form 8-K. The information contained in this presentation is as of the date indicated. The Company assumes
no obligation to update any forward-looking statements contained in this presentation as a result of new information or future events or developments.
This presentation refers to certain non-GAAP financial measures. Refer to 3M’s October 26, 2021, press release for descriptions of non-GAAP financial measures
such free cash flow, adjusted free cash flow, free cash flow conversion, adjusted free cash flow conversion, net debt, adjusted EBITDA, and various measures that
adjust for the impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of
these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in that press release.
Note on non-GAAP financial measures

-- 3 of 16 --

44	2021 Q3 Earnings – October 26, 2021. All rights reserved.
3M delivers strong performance in a dynamic environment
KEY TAKEAWAYS
• Strong and growing segments delivered organic growth across all business groups and geographic areas
• Delivered in the face of a challenging environment; focused on serving customers while navigating global supply chains,
raw materials and logistics environment
• Global end-market and customer demand remains strong
• Semiconductor constraints impacting end-markets, particularly automotive and electronics; healthcare and oral care
elective procedures expected to remain stable with recent trends
• Gaining traction on selling price increases to help mitigate inflationary headwinds
• Prioritizing investments in growth, productivity and sustainability
• Updating full-year 2021 guidance range to reflect ongoing supply chain, raw materials and logistics challenges
Organic local-currency
growth Operating margin Earnings per share
+6.3% / +11.5% 20.0% / 21.5% $2.45 / $7.81	Q3 / YTD

-- 4 of 16 --

55	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Our areas of investment align with key global trends
Targeting growth above macro in attractive markets
Automotive
• Technologies to improve energy efficiency and help make transportation safer,
smarter and more connected
Home improvement
• Innovations that help consumers personalize their homes and keep families
healthier and more productive, including our fast-growing Command™
damage-free hanging solutions and Filtrete™ filter brands
Personal safety
• Science-based solutions for respiratory, face, hearing and fall protection
Biopharma filtration
• Innovations that help pharmaceutical companies advance the development and
manufacturing of therapeutics and vaccines
Electronics and software
• Solutions that enable better performance and connectivity while improving
productivity, speed and agility for customers

-- 5 of 16 --

66	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Q3 2021 operating margin and EPS
+9.0%
Operating
Income Margin
Earnings Per
Share
Q3 2020 22.9% $2.45
Organic volume/productivity
and other -1.4% -$0.02
Q3 2021 organic volume +4.9; productivity penalties from global supply chain
challenges; restructuring savings offsetting restructuring charge; increased
investments in growth and sustainability; increased litigation-related costs
Price/raw material -1.3% -$0.12 Selling price increases more than offset by higher raw materials and logistics costs
FX -0.2% -$0.01 Net of hedge impact; full-year 2021 FX benefit of approximately $0.15 per share,
remains unchanged
Other expense/income NA +$0.08 Primarily non-operating pension benefit and lower net interest expense
Tax rate* NA +$0.09 Q3 2021 tax rate 18.4% versus 21.5% in prior year; full-year 2021 tax rate expected
in range of 18.5% to 19.5% vs. 20% to 21% previously
Shares outstanding NA -$0.02 Average diluted shares up 1%
Q3 2021 20.0% $2.45
* The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above.

-- 6 of 16 --

77	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Q3 2021 cash flow and balance sheet
Proactive balance sheet management
• Net debt of $12.4B, down $2.6B, or 17% year-on-year
Adjusted free cash flow
• Q3: $1.5B, down 29%; YTD: $4.5B, down 3% year-on-year
Adjusted free cash flow conversion
• Q3: 107%, down 44 ppts; YTD: 98%, down 26 ppts
• Year-on-year decline primarily due to strong customer demand and
supply chain challenges which increased working capital
Capital expenditures
• Q3: $343M; YTD $1.0B
• FY 2021: $1.5B to $1.6B versus $1.8B to $2.0B, previously
Cash returned to shareholders
• Dividends: Q3 $856M; YTD $2.6B
• Gross share repurchases: Q3 $527M; YTD $1.3B
$1.5B
-29% year-on-year
Adjusted free cash
flow
107%
-44 ppts year-on-year
Adjusted free cash
flow conversion
$1.4B
+63% year-on-year
Cash returned to
shareholders

-- 7 of 16 --

88	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Q3 Business Group performance
Organic
Growth
Segment
Operating
Margin Commentary
Safety &
Industrial +6.1% 19.2%
• Organic growth led by general industrial with strength in adhesives and tapes, and abrasives;
roofing granules down due to strong year-on-year comp; personal safety declined due to prior-
year strong COVID-related respiratory demand
• Disposable respirator sales declined 7% organically year-on-year, and 15% sequentially
• Operating margins -6.5 ppts year-on-year; increases in raw materials, logistics and litigation-
related costs, partially offset by sales growth
Transportation
& Electronics +5.1% 19.0%
• Organic growth led by advanced materials, commercial solutions, transportation safety; auto
OEM continues to outpace global car and light truck builds; organic sales declined in
electronics due to continued impact of semiconductor constraints on customers
• Operating margins -3.2 ppts year-on-year; increases in raw materials and logistics costs,
partially offset by sales growth
Health Care +3.3% 23.5%
• Organic growth led by food safety, oral care, and health information systems; declined in
medical solutions due to lower year-on-year disposable respirator sales
• Operating margins +0.7 ppts year-on-year; improvement due to sales growth, partially offset
by rising raw materials and logistics costs
Consumer +7.6% 21.7%
• Continued strength in home improvement and home cleaning; improving office and stationery
demand driven by return-to-school
• Operating margins -2.6 ppts year-on-year; increases in raw materials, logistics, outsourced
hardgoods manufacturing costs, partially offset by sales growth

-- 8 of 16 --

99	2021 Q3 Earnings – October 26, 2021. All rights reserved.
2021 planning estimates
Macro and business trends Q4 vs. Q3 2021 sequential items of note
• Global end-market demand remains strong
• Semiconductor constraints impacting end-markets, particularly
automotive and electronics
• Healthcare and oral care elective procedures expected to
remain stable with recent trends
• Significant global supply chain, raw materials and logistics
challenges expected to persist into foreseeable future
• Full-year raw material and logistics headwinds of $0.80 to
$0.90 per share, responding with selling price increases, dual
sourcing and yield improvement
• Maintaining strong execution and operating rigor
• One fewer business day versus Q3 2021
• Focused on serving customers while navigating supply chain,
raw materials and logistics challenges
• Selling price expected to continue to gain traction
• Lower pandemic-related disposable respiratory demand of
$25M to $75M sequentially ($125M to $175M year-on-year)
• Expecting increase in legal-related costs
• Previously announced (Dec 2020) restructuring program on
track, expected Q4 pre-tax charge of $25M to $50M, similar to
Q3 2021
• Higher investments in growth, productivity and sustainability
Organic local-currency growth
8% to 9% vs.
6% to 9%, prior
Earnings per share
$9.70 to $9.90 vs.
$9.70 to $10.10, prior
Free cash flow conversion
90% to 100%,
unchanged

-- 9 of 16 --

10	10	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Q&A
Mike Roman
Chairman of the Board &
Chief Executive Officer
Monish Patolawala
Executive Vice President, Chief
Financial & Transformation
Officer
Bruce Jermeland
Senior Vice President,
Investor Relations

-- 10 of 16 --

1111	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Appendix

-- 11 of 16 --

12	12	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Q3 2021 P&L
($M)
Q3
2020
Q3
2021 Change
Sales $8,350 $8,942 +7.1%
Gross profit $4,047 $4,089 +1.0%
% to sales 48.5% 45.7% -2.8 pts
SG&A $1,677 $1,819 +8.4%
% to sales 20.1% 20.3% +0.2 pts
R&D & related $461 $482 +4.4%
% to sales 5.5% 5.4% -0.1 pts
Gain on sale of businesses — — —
% to sales — — —
Operating income $1,909 $1,788 -6.3%
% to sales 22.9% 20.0% -2.9 pts
Net income $1,430 $1,434 +0.3%
GAAP earnings per share $2.45 $2.45 -0.3%

-- 12 of 16 --

13	13	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Q3 2021 sales recap
Americas EMEA APAC Worldwide
Organic volume +5.4% +3.1% +5.1% +4.9%
Price +2.0% +1.1% +0.5% +1.4%
Organic local-currency +7.4% +4.2% +5.6% +6.3%
Acquisitions/divestitures —% —% —% —%
FX +0.5% +1.0% +1.2% +0.8%
Total growth +7.9% +5.2% +6.8% +7.1%
U.S. Canada Mexico Brazil China/HK Japan
Organic local-currency +6% +7% +12% +22% +3% +6%

-- 13 of 16 --

14	14	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Business segment information
($M) Net Sales Q3 2021 Sales Growth
Organic local-currency
by Geographic Area
Business Segment Operating
Income/Adjusted Operating
Income*
Business Segment
Operating
Margin/Adjusted
Operating Margin*
Business groups
Q3
2020
Q3
2021
Organic
local-
currency FX M&A
Total
Sales
Change Americas
Asia
Pacific EMEA
Q3
2020
Q3
2021
Percent
change
Q3
2020
Q3
2021
Safety & Industrial $3,017 $3,235 6.1% 1.1% —% 7.2% 4.9% 15.6% -0.8% $774 $620 -19.9% 25.7% 19.2%
Transportation &
Electronics $2,316 $2,450 5.1% 0.7% —% 5.8% 13.3% -0.2% 11.3% $514 $465 -9.4% 22.2% 19.0%
Health Care $2,160 $2,249 3.3% 0.8% —% 4.1% 1.4% 10.9% 3.1% $493 $529 7.2% 22.8% 23.5%
Consumer $1,412 $1,525 7.6% 0.5% —% 8.1% 9.5% 3.8% -0.6% $343 $332 -3.3% 24.3% 21.7%
Elimination of Dual
Credit $(553) $(520) $(142) $(131)
Total Operating
Business Segment $1,982 $1,815
Corporate & Unallocated $(2) $3 $(73) $(27)
Total $8,350 $8,942 6.3% 0.8% —% 7.1% 7.4% 5.6% 4.2% $1,909 $1,788 -6.3% 22.9% 20.0%
* “Corporate and Unallocated” and “Total” provided on an adjusted basis
Organic local-currency = organic volume + price

-- 14 of 16 --

15	15	2021 Q3 Earnings – October 26, 2021. All rights reserved.
Additional sales detail
($M) Net Sales
Business groups Q3 2020 Q3 2021
Abrasives 289 362
Automotive Aftermarket 308 314
Closure and Masking Systems 242 264
Electrical Materials 285 322
Industrial Adhesives & Tapes 643 760
Personal Safety 1,136 1,105
Roofing Granules 113 109
Other Safety & Industrial 1 (1)
Total Safety & Industrial Business Group 3,017 3,235
Advanced Materials 247 305
Automotive & Aerospace 410 439
Commercial Solutions 391 457
Electronics 1,025 1,000
Transportation Safety 245 250
Other Transportation & Electronics (2 ) (1)
Total Transportation & Electronics Business Group 2,316 2,450
($M) Net Sales
Business groups Q3 2020 Q3 2021
Drug Delivery — —
Food Safety 83 96
Health Information Systems 280 309
Medical Solutions 1,251 1,241
Oral Care 320 359
Separation & Purification Sciences 221 244
Other Health Care 5 —
Total Health Care Business Group 2,160 2,249
Consumer Health & Safety 139 152
Home Care 268 278
Home Improvement 644 699
Stationery & Office 318 355
Other Consumer 43 41
Total Consumer Business Group 1,412 1,525
Corporate & Unallocated (2) 3
Elimination of Dual Credit (553) (520)
Total 8,350 8,942

-- 15 of 16 --



-- 16 of 16 --